tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
BBIO is currently covered by 11 analysts with an average price target of $71.08. This is a potential upside of $19.59 (38.05%) from yesterday's end of day stock price of $51.49.
BridgeBio Pharma's activity chart (see below) currently has 122 price targets and 132 ratings on display. The stock rating distribution of BBIO is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 77.61% with an average time for these price targets to be met of 289.47 days.
Highest price target for BBIO is $95, Lowest price target is $46, average price target is $63.55.
Most recent stock forecast was given by ELIANA MERLE from UBS on 12-Sep-2025. First documented stock forecast 22-Jul-2019.
Currently out of the existing stock ratings of BBIO, 57 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$82
$30.79 (60.12%)
$72
4 days ago
(12-Sep-2025)
4/7 (57.14%)
$30.79 (60.12%)
342
Buy
$70
$18.79 (36.69%)
$50
13 days ago
(03-Sep-2025)
13/15 (86.67%)
$18.16 (35.03%)
176
Buy
$70
$18.79 (36.69%)
$70
13 days ago
(03-Sep-2025)
21/27 (77.78%)
$18.16 (35.03%)
315
Buy
$57
$5.79 (11.31%)
$55
1 months 10 days ago
(06-Aug-2025)
7/9 (77.78%)
$12.19 (27.20%)
225
Buy
$95
$43.79 (85.51%)
$95
1 months 18 days ago
(29-Jul-2025)
3/10 (30%)
$48.68 (105.09%)
491
What is BBIO (BridgeBio Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on BBIO (BridgeBio Pharma) with a proven track record?
Which analyst has the most public recommendations on BBIO (BridgeBio Pharma)?
Which analyst is the currently most bullish on BBIO (BridgeBio Pharma)?
Which analyst is the currently most reserved on BBIO (BridgeBio Pharma)?
